INHIBITING INVASION AND STEMNESS IN GLIOBLASTOMA BY THYMOSIN BETA 4 GENE SILENCING: A POTENTIAL THERAPEUTIC TARGET?
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii21, doi. 10.1093/neuonc/nou206.79
- By:
- Publication type:
- Article
Works by Hasenbach, Kathy
Results: 7
1
2
Monitoring the glioma tropism of bone marrow–derived progenitor cells by 2-photon laser scanning microscopy and positron emission tomography.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 4, p. 471, doi. 10.1093/neuonc/nor228
- By:
- Publication type:
- Article
3
APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 2, p. 155, doi. 10.1093/neuonc/noq176
- By:
- Publication type:
- Article
4
Thymosin β 4 gene silencing decreases stemness and invasiveness in glioblastoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
5
Thymosin beta 4 gene silencing decreases stemness and invasiveness in glioblastoma.
- Published in:
- Brain: A Journal of Neurology, 2014, v. 137, n. 2, p. 433, doi. 10.1093/brain/awt333
- By:
- Publication type:
- Article
6
Integrin control of the transforming growth factor-[beta] pathway in glioblastoma.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
7
Integrin control of the transforming growth factor-β pathway in glioblastoma.
- Published in:
- Brain: A Journal of Neurology, 2013, v. 136, n. 2, p. 564, doi. 10.1093/brain/aws351
- By:
- Publication type:
- Article